Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   ACTA MEDICA IRANICA   NOVEMBER-DECEMBER 2004 , Volume 42 , Number 6; Page(s) 419 To 423.
 
Paper: 

CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?

 
 
Author(s):  MODARES GILANI M., GHAEM MAGHAMI FATEMEH, ANSARIPOUR S., SHARIAT M., ZAERI F.
 
* 
 
Abstract: 
Larger tumor burden leads to higher serum CA-125 levels and the ability to perform optimal tumor cytoreduction of advanced ovarian cancer is also a function of tumor bulk. The purpose of this study was to identify the ability of preoperative serum CA-125 to predict possibility of optimal primary tumor cytoreduction in epithelial ovarian carcinoma (EOC). A total of 90 patients with EOC were evaluated in a prospective study from 2000 to 2002. Preoperative serum CA-125 levels were determined, using a solid phase immunoassay. We used a receiver operating characteristic curve to identify the CA-125 level with the maximal prognostic power in predicting optimal versus suboptimal debulking. The median CA-125 level for the 90 patients was 500 U/ml (range 13 to 5000 U/ml). Seventy patient (78%) had stage III or ?V based on staging system of the International Federation of Gynecology and Obstetrics (FIGO) for ovarian carcinoma. Optimal cytoreduction (diameter of largest residual tumor less than 1 cm) was obtained in 44 patients (62.9%) with stage III-?V. Preoperative CA- 125 value less than 450 U/ml had a positive predictive value for optimal cytoreduction of 78%, but a poor negative predictive value of 50% in advanced EOC. In patients with advanced EOC, at a cutoff 450 U/ml, 78% underwent optimal debulking, whereas 50% of patients with preoperative CA-125 level above 450 U/ml were still able to undergo optimal debulking. Preoperative CA-125 does not seem to be a reliable predictor of optimal cytoreduction.
 
Keyword(s): PREOPERATIVE CA-125 , RESECTABILITY , EPITHELIAL OVARIAN CARCINOMA
 
 
References: 
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

MODARES GILANI, M., & GHAEM MAGHAMI, F., & ANSARIPOUR, S., & SHARIAT, M., & ZAERI, F. (2004). CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?. ACTA MEDICA IRANICA, 42(6), 419-423. https://www.sid.ir/en/journal/ViewPaper.aspx?id=13599



Vancouver: Copy

MODARES GILANI M., GHAEM MAGHAMI FATEMEH, ANSARIPOUR S., SHARIAT M., ZAERI F.. CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?. ACTA MEDICA IRANICA. 2004 [cited 2021June14];42(6):419-423. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=13599



IEEE: Copy

MODARES GILANI, M., GHAEM MAGHAMI, F., ANSARIPOUR, S., SHARIAT, M., ZAERI, F., 2004. CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?. ACTA MEDICA IRANICA, [online] 42(6), pp.419-423. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=13599.



 
  pdf-File
Yearly Visit 52
 
 
Latest on Blog
Enter SID Blog